Live coverage has ended. The full story is below.
This article will be updated throughout the day, so check back often for more daily updates.
The Vanguard S&P 500 ETF (NYSEMKT: VOO) looks pretty flat this morning, up at most 0.02% premarket, as investors consider a new forecast from the Organization for Economic Cooperation and Development.
According to the OECD, the global economy will slow only slightly this year, growing 3.2% versus 3.3% in 2024. This is considered good news because as recently as June, the OECD was forecasting even slower growth of 2.9% this year.
The forecast for 2026 stands at 2.9%. So while today’s updated growth predictions are stronger than what we were looking at previously, the long term trend is still down, with 2025 growth weaker than 2024, and 2026 weaker than 2025.
In more micro-economic news, consumer medical products maker Kenvue (NYSE: KVUE | KVUE Price Prediction), which spun off from Johnson & Johnson (NYSE: JNJ) in 2023, sank 7.5% yesterday after the Trump Administration Department of Health and Human Services warned that taking Tylenol during pregnancy may be linked with autism. Today the Tylenol manufacturer is winning back most of its losses and up 6.5% premarket.
Finally, Nvidia (Nasdaq: NVDA) stock is down nearly 1%, one day after jumping 4% on news that the maker of artificial intelligence semiconductors is investing $100 billion in OpenAI, the country’s leading AI provider and the company behind ChatGPT.
Earnings
Automotive parts store chain AutoZone (NYSE: AZO) missed earnings badly this morning, reporting a Q4 profit of only $48.71 per share, $2.22 worse than Wall Street had predicted. Revenue for the quarter, however, matched forecasts exactly at $6.24 billion.
AutoZone stock is down about 2.2% premarket.
Contact [email protected] for any questions or corrections.